Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature Infants

NCT06035835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 437

Last updated 2023-09-13

No results posted yet for this study

Summary

The purpose of this study is assess if the use of probiotic in very low weight could be other benefits a long time, as reduce atopic disease in this children.

Conditions

Interventions

COMBINATION_PRODUCT

Lacticaseibacillus rhamnosus

Administration Lacticaseibacillus rhamnosus (L. Rhamnosus) ATCC 53103 (109 UFC/day)

COMBINATION_PRODUCT

Lactobacillus acidophilus + Bifidobacterium bifidum

Administration Lactobacillus acidophilus (L. acidophilus) ATCC 4356 (109 UFC/12 h)+Bifidobacterium bifidum (B. bifidum) ATCC 15696 (109 UFC/12 h)

Sponsors & Collaborators

  • José Uberos Fernández

    lead OTHER

Principal Investigators

  • José Uberos-Fernández, Mr · Hospital Clinico Universitario San Cecilio

Eligibility

Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2021-12-31
Completion
2022-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06035835 on ClinicalTrials.gov